• About Us
    • Company History
  • Services
    • At a Glance
    • In vitro DMPK & Pharmacology
      • Physicochemical Properties
      • Chemical Stability
      • In vitro Binding
      • Metabolic Stability
      • Permeability & Transporter Services
      • Reaction Phenotyping
      • CYP Inhibition
      • CYP Induction
      • Pharmacology Assay Development
      • Customised Laboratory Services
    • PK, Bioanalysis & Metabolite Identification
      • Bioanalysis Overview
      • Bioanalysis Services
      • Metabolite Identification
      • Pharmacokinetics (PK)
      • Metabolite Bulk-Up & Isolation (mg to g)
    • Modelling & Simulation
    • ADME Packages
      • Pharmacokinetics
      • Absorption
      • Oral Exposure
      • Human PK & Dose Prediction
    • Formulation Services
    • Due Diligence
      • Hit/Lead Compounds
      • Clinical Candidate
  • Latest
    • Blog
    • Events
    • News
  • Partners
    • Axis BioServices
    • BioAscent
    • Charnwood Molecular
    • Medicines Discovery Catapult
    • Reach Separations
    • Saretius
    • TherapeutAix
  • Meet The Team
  • Resources
    • Articles
    • Posters
    • Presentations
    • Publications
    • Videos
  • Contact Us
  • Join Us
XenoGesis XenoGesis
  • About Us
    • Company History
  • Services
    • At a Glance
    • In vitro DMPK & Pharmacology
      • Physicochemical Properties
      • Chemical Stability
      • In vitro Binding
      • Metabolic Stability
      • Permeability & Transporter Services
      • Reaction Phenotyping
      • CYP Inhibition
      • CYP Induction
      • Pharmacology Assay Development
      • Customised Laboratory Services
    • PK, Bioanalysis & Metabolite Identification
      • Bioanalysis Overview
      • Bioanalysis Services
      • Metabolite Identification
      • Pharmacokinetics (PK)
      • Metabolite Bulk-Up & Isolation (mg to g)
    • Modelling & Simulation
    • ADME Packages
      • Pharmacokinetics
      • Absorption
      • Oral Exposure
      • Human PK & Dose Prediction
    • Formulation Services
    • Due Diligence
      • Hit/Lead Compounds
      • Clinical Candidate
  • Latest
    • Blog
    • Events
    • News
  • Partners
    • Axis BioServices
    • BioAscent
    • Charnwood Molecular
    • Medicines Discovery Catapult
    • Reach Separations
    • Saretius
    • TherapeutAix
  • Meet The Team
  • Resources
    • Articles
    • Posters
    • Presentations
    • Publications
    • Videos
  • Contact Us
  • Join Us
Latest News

XenoGesis take home Medlink Export Achievement Award

December 6, 2019
suecarr 2019-12-06T15:08:01+00:00
Ada Lovelace Day 2019
Latest News

Ada Lovelace Day 2019

October 14, 2019
suecarr 2019-10-14T12:24:03+00:00
Pharma Integrates
Latest News

Richard Weaver to join panel at Pharma Integrates

October 9, 2019
suecarr 2019-10-09T13:24:02+00:00
ELRIG Drug Discovery
About Us, Latest News

XenoGesis exhibiting at ELRIG Drug Discovery 2019

October 9, 2019
suecarr 2019-10-09T12:21:53+00:00
IoD Awards
Latest News

Richard Weaver shortlisted in IoD Director of the Year Awards 2019

October 9, 2019
suecarr 2019-10-09T11:07:39+00:00
candidate drug against malaria
Latest News

Innovative candidate drug against malaria offers considerable potential

September 23, 2019
suecarr 2019-09-23T12:15:15+00:00
Biotech hubs in the USA
About Us, Latest News

XenoGesis bolsters profile and relationships in the US West Coast region

September 18, 2019
suecarr 2019-09-18T08:57:16+00:00
East Midlands Director of the Year
Latest News

Richard Weaver wins IoD East Midlands Director of the Year Award

June 22, 2019
suecarr 2019-06-22T10:38:38+00:00
XenoGesis export growth
Latest News

XenoGesis reports rapid export growth

May 8, 2019
suecarr 2019-05-08T10:41:10+00:00
Latest News

Rachel Hemsley appointed to the BioPartner Advisory Board

May 8, 2019
suecarr 2019-05-08T10:40:11+00:00

Posts navigation

1 2 Next Page
Contact Us
XenoGesis Ltd
  • BioCity Nottingham, Pennyfoot Street, Nottingham, Nottinghamshire, NG1 1GF, United Kingdom
  • BioHub, Alderley Park, Alderley Edge, Cheshire, SK10 4TG, United Kingdom
  • Telephone: +44 (0)115 837 0626
  • Email: info@xenogesis.com
Services
  • In vitro DMPK & Pharmacology
  • PK, Bioanalysis & Metabolite Identification
  • Modelling & Simulation
  • ADME Packages
  • Formulation Services
  • Due Diligence
Latest News
  • XenoGesis take home Medlink Export Achievement Award
  • Ada Lovelace Day 2019
  • Richard Weaver to join panel at Pharma Integrates
Follow Us

© 2019 XenoGesis | BioCity Nottingham | Pennyfoot Street | Nottingham | NG1 1GF | UK

  • Privacy Policy

Our site uses cookies. Learn more about our use of cookies: cookie policy

I accept